{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T03:45:08Z","timestamp":1725853508562},"publisher-location":"Cham","reference-count":135,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319299969"},{"type":"electronic","value":"9783319299983"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-3-319-29998-3_5","type":"book-chapter","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T09:35:18Z","timestamp":1460626518000},"page":"61-83","source":"Crossref","is-referenced-by-count":2,"title":["Diagnosis and Management of Hereditary Pancreatic Cancer"],"prefix":"10.1007","author":[{"given":"Jeremy L.","family":"Humphris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew V.","family":"Biankin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"5_CR1","unstructured":"(AIHW) A. I. O. H. A. W. (2014) Australian cancer incidence and mortality (ACIM) books: pancreatic cancer. AIHW, Canberra. http:\/\/www.aihw.gov.au\/acim-books%3E"},{"issue":"4","key":"5_CR502","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s11605-011-1781-6","volume":"16","author":"Wigdan Al-Sukhni","year":"2011","unstructured":"Al-Sukhni W, Borgida A, Rothenmund H, Holter S, Semotiuk K, Grant R et al (2012). Screening for pancreatic cancer in a high-risk cohort: an eight-year experience. J Gastrointest Surg: official J Soc Surg Aliment Tract 16(4):771\u2013783","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1097\/mpa.0b013e31814de421","volume":"36","author":"B Agarwal","year":"2008","unstructured":"Agarwal B, Correa AM, Ho L (2008) Survival in pancreatic carcinoma based on tumor size. Pancreas 36:e15\u2013e20","journal-title":"Pancreas"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.celrep.2012.12.008","volume":"3","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Campbell PJ, Stratton MR (2013) Deciphering signatures of mutational processes operative in human cancer. Cell Rep 3:246\u2013259","journal-title":"Cell Rep"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/ajg.2012.288","volume":"107","author":"M Anderson","year":"2012","unstructured":"Anderson M, Zolotarevsky E, Cooper K et al (2012) Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study. Am J Gastroenterol 107:1730\u20131739. doi: 10.1038\/ajg.2012.288 Epub 2012 Aug 28","journal-title":"Am J Gastroenterol"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/archinternmed.2010.63","volume":"170","author":"AA Arslan","year":"2010","unstructured":"Arslan AA, Helzlsouer KJ, Kooperberg C et al (2010) Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med 170:791\u2013802","journal-title":"Arch Intern Med"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4161\/cbt.8.2.7136","volume":"8","author":"JE Axilbund","year":"2009","unstructured":"Axilbund JE, Argani P, Kamiyama M et al (2009) Absence of germline BRCA1 mutations in familial pancreatic cancer patients. Cancer Biol Ther 8:131\u2013135","journal-title":"Cancer Biol Ther"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/jech.56.12.899","volume":"56","author":"A Barratt","year":"2002","unstructured":"Barratt A, Mannes P, Irwig L, Trevena L, Craig J, Rychetnik L (2002) Cancer screening. J Epidemiol Commun Health 56:899\u2013902","journal-title":"J Epidemiol Commun Health"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s11605-011-1417-x","volume":"15","author":"J Barton","year":"2011","unstructured":"Barton J, Schnelldorfer T, Lohse C et al (2011) Patterns of pancreatic resection differ between patients with familial and sporadic pancreatic cancer. J Gastrointest Surg 15:836\u2013842. doi: 10.1007\/s11605-011-1417-x Epub 2011 Feb 26","journal-title":"J Gastrointest Surg"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/ijc.20210","volume":"110","author":"D Bartsch","year":"2004","unstructured":"Bartsch D, Kress R, Sina-Frey M et al (2004) Prevalence of familial pancreatic cancer in Germany. Int J Cancer 110:902\u2013906","journal-title":"Int J Cancer"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrgastro.2012.111","volume":"9","author":"D Bartsch","year":"2012","unstructured":"Bartsch D, Gress T, Langer P (2012) Familial pancreatic cancer\u2013current knowledge. Nat Rev Gastroenterol Hepatol 9:445\u2013453. doi: 10.1038\/nrgastro.2012.111 Epub 2012 Jun 5","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/gut.2009.198499","volume":"59","author":"AD Beggs","year":"2010","unstructured":"Beggs AD, Latchford AR, Vasen HFA et al (2010) Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut 59:975\u2013986","journal-title":"Gut"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.7326\/0003-4819-123-3-199508010-00005","volume":"123","author":"P Berthelemy","year":"1995","unstructured":"Berthelemy P, Bouisson M, Escourrou J et al (1995) Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 123:188\u2013191","journal-title":"Ann Intern Med"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1038\/sj.onc.1204621","volume":"20","author":"JM Birch","year":"2001","unstructured":"Birch JM, Alston RD, McNally R et al (2001) Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20:4621\u20134628","journal-title":"Oncogene"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/annonc\/mdr541","volume":"23","author":"C Bosetti","year":"2012","unstructured":"Bosetti C, Lucenteforte E, Silverman DT et al (2012) Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol 23:1880\u20131888","journal-title":"Ann Oncol"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1136\/gut.2006.108456","volume":"56","author":"RE Brand","year":"2007","unstructured":"Brand RE, Lerch MM, Rubinstein WS et al (2007) Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 56:1460\u20131469","journal-title":"Gut"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"91","author":"Breast Cancer Linkage Consortimu","year":"1999","unstructured":"Breast Cancer Linkage Consortimu (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:1310\u20131316","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"5_CR503","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-131-4-199908170-00003","volume":"131","author":"Teresa A. Brentnall","year":"1999","unstructured":"Brentnall T, Bronner M, Byrd D, Haggitt R, Kimmey M (1999). Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 131(4):247\u2013255","journal-title":"Annals of Internal Medicine"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"e30219","DOI":"10.1371\/journal.pone.0030219","volume":"7","author":"TA Brentnall","year":"2012","unstructured":"Brentnall TA, Lai LA, Coleman J et al (2012) Arousal of cancer-associated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion. PLoS ONE 7:e30219","journal-title":"PLoS ONE"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","volume":"94","author":"MS Brose","year":"2002","unstructured":"Brose MS, Rebbeck TR, Calzone KA et al (2002) Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 94:1365\u20131372","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"5_CR500","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/jnci\/djp466","volume":"102","author":"K. A. Brune","year":"2010","unstructured":"Brune K, Lau B, Palmisano E, Canto M, Goggins M, Hruban R et al (2010). Importance of age of onset in pancreatic cancer kindreds. J Natl Cancer Inst 102(2):119\u201326. doi: 10.1093\/jnci\/djp466 . Epub 2010 Jan 12","journal-title":"JNCI Journal of the National Cancer Institute"},{"issue":"6","key":"5_CR506","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.cgh.2006.02.005","volume":"4","author":"Marcia Irene Canto","year":"2006","unstructured":"Canto M, Goggins M, Hruban R, Petersen G, Giardiello F, Yeo C et al (2006). Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 4(6):766\u2013781; quiz 665. Epub 2006 May 6","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"7","key":"5_CR505","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S1542-3565(04)00244-7","volume":"2","author":"Marcia Irene Canto","year":"2004","unstructured":"Canto M, Goggins M, Yeo C, Griffin C, Axilbund J, Brune K, et al (2004). Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2(7):606\u2013621","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"4","key":"5_CR512","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1053\/j.gastro.2012.01.005","volume":"142","author":"Marcia Irene Canto","year":"2012","unstructured":"Canto M, Hruban R, Fishman E, Kamel I, Schulick R, Zhang Z et al (2012). Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142(4):796\u2013804; quiz e14-5. doi: 10.1053\/j.gastro.2012.01.005 . Epub Jan 12.","journal-title":"Gastroenterology"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/gutjnl-2012-303108","volume":"62","author":"MI Canto","year":"2013","unstructured":"Canto MI, Harinck F, Hruban RH et al (2013a) International Cancer of the Pancreas Screening (CAPS) consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 62:339\u2013347","journal-title":"Gut"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/gutjnl-2012-303108","volume":"62","author":"MI Canto","year":"2013","unstructured":"Canto MI, Harinck F, Hruban RH et al (2013b) International Cancer of the Pancreas Screening (CAPS) consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 62:339\u2013347","journal-title":"Gut"},{"issue":"28","key":"5_CR22","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1200\/JCO.2015.61.6961","volume":"33","author":"Julia Carnevale","year":"2015","unstructured":"Carnevale J, Ashworth A (2015) Assessing the Significance of BRCA1 and BRCA2 mutations in pancreatic cancer. J Clin Oncol JCO 2015 OCT 1; 33(28):3080\u20133081","journal-title":"Journal of Clinical Oncology"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/jcp.2004.020925","volume":"58","author":"R Chetty","year":"2005","unstructured":"Chetty R, Salahshor S, Bapat B et al (2005) Intraductal papillary mucinous neoplasm of the pancreas in a patient with attenuated familial adenomatous polyposis. J Clin Pathol 58:97\u2013101","journal-title":"J Clin Pathol"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s12029-008-9022-2","volume":"38","author":"M Cote","year":"2007","unstructured":"Cote M, Schenk M, Schwartz A et al (2007) Risk of other cancers in individuals with a family history of pancreas cancer. J Gastrointest Cancer. 38:119\u2013126. doi: 10.1007\/s12029-008-9022-2","journal-title":"J Gastrointest Cancer."},{"key":"5_CR25","doi-asserted-by":"crossref","unstructured":"Cotterchio M, Lowcock E, Hudson TJ et al (2014) Association between allergies and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev","DOI":"10.1158\/1055-9965.EPI-13-0965"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1158\/1055-9965.EPI-06-0783","volume":"16","author":"F Couch","year":"2007","unstructured":"Couch F, Johnson M, Rabe K et al (2007a) The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol Biomarkers Prev 16:342\u2013346","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1158\/1055-9965.EPI-06-0783","volume":"16","author":"FJ Couch","year":"2007","unstructured":"Couch FJ, Johnson MR, Rabe KG et al (2007b) The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol Biomarkers Prev 16:342\u2013346","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5_CR29","unstructured":"Couch FJ, Hart SN, Sharma P et al (2014) Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.dld.2010.04.016","volume":"42","author":"M Chiaro del","year":"2010","unstructured":"del Chiaro M, Zerbi A, Capurso G et al (2010) Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry. Dig Liver Dis 42:597\u2013605","journal-title":"Dig Liver Dis"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/annonc\/mds140","volume":"23","author":"EJ Duell","year":"2012","unstructured":"Duell EJ, Lucenteforte E, Olson SH et al (2012) Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol 23:2964\u20132970","journal-title":"Ann Oncol"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1158\/1055-9965.EPI-10-1196","volume":"20","author":"RC Eldridge","year":"2011","unstructured":"Eldridge RC, Gapstur SM, Newton CC et al (2011) Jewish ethnicity and pancreatic cancer mortality in a large U.S. Cohort Cancer Epidemiol Biomarkers Prev 20:691\u2013698","journal-title":"Cohort Cancer Epidemiol Biomarkers Prev"},{"key":"5_CR32","unstructured":"Ferlay JSI, Ervik M, Dikshit R et al (2013) Globocan 2012 v1.0, cancer incidence and mortality worldwide: IARC cancerbase no. 11 [Internet]. International Agency for Research on Cancer, Lyon, France. Available from: http:\/\/globocan.iarc.fr . Accessed on 14 Dec 2015"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1200\/JCO.2008.18.5546","volume":"27","author":"CR Ferrone","year":"2009","unstructured":"Ferrone CR, Levine DA, Tang LH et al (2009) BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma. J Clin Oncol 27:433\u2013438","journal-title":"J Clin Oncol"},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1245\/s10434-012-2621-y","volume":"20","author":"J Franko","year":"2013","unstructured":"Franko J, Hugec V, Lopes T, Goldman C (2013) Survival Among Pancreaticoduodenectomy Patients Treated for Pancreatic Head Cancer\u00a0<1 or 2\u00a0cm. Ann Surg Oncol 20:357\u2013361","journal-title":"Ann Surg Oncol"},{"key":"5_CR35","first-page":"6094","volume":"51","author":"JE Garber","year":"1991","unstructured":"Garber JE, Goldstein AM, Kantor AF et al (1991) Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res 51:6094\u20136097","journal-title":"Cancer Res"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1158\/1055-9965.EPI-08-0880","volume":"18","author":"JM Genkinger","year":"2009","unstructured":"Genkinger JM, Spiegelman D, Anderson KE et al (2009) Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. Cancer Epidemiol Biomarkers Prev 18:765\u2013776","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5_CR37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF02924156","volume":"10","author":"P Ghadirian","year":"1991","unstructured":"Ghadirian P, Boyle P, Simard A et al (1991) Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal. Can Int J Pancreatol 10:183\u2013196","journal-title":"Can Int J Pancreatol"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/jmedgenet-2011-100281","volume":"49","author":"P Ghiorzo","year":"2012","unstructured":"Ghiorzo P, Fornarini G, Sciallero S et al (2012) CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. J Med Genet 49:164\u2013170","journal-title":"J Med Genet"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1136\/gut.34.10.1394","volume":"34","author":"FM Giardiello","year":"1993","unstructured":"Giardiello FM, Offerhaus GJ, Lee DH, Krush AJ, Tersmette AC, Booker SV, Kelley NC, Hamilton SR (1993) Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 34:1394\u20131396","journal-title":"Gut"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1158\/1078-0432.CCR-10-3074","volume":"17","author":"M Goggins","year":"2011","unstructured":"Goggins M (2011) Markers of pancreatic cancer: working toward early detection. Clin Cancer Res 17:635\u2013637","journal-title":"Clin Cancer Res"},{"key":"5_CR41","first-page":"5360","volume":"56","author":"M Goggins","year":"1996","unstructured":"Goggins M, Schutte M, Lu J et al (1996) Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 56:5360\u20135364","journal-title":"Cancer Res"},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1158\/1055-9965.EPI-10-0667","volume":"19","author":"DV Gold","year":"2010","unstructured":"Gold DV, Goggins M, Modrak DE et al (2010) Detection of early-stage pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev 19:2786\u20132794","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5_CR43","doi-asserted-by":"crossref","unstructured":"Grant RC, Selander I, Connor AA et al (2014) Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. Gastroenterology","DOI":"10.1053\/j.gastro.2014.11.042"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(02)07948-5","volume":"359","author":"DA Grimes","year":"2002","unstructured":"Grimes DA, Schulz KF (2002) Uses and abuses of screening tests. Lancet 359:881\u2013884","journal-title":"Lancet"},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/0092-8674(81)90021-0","volume":"66","author":"J Groden","year":"1991","unstructured":"Groden J, Thliveris A, Samowitz W et al (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589\u2013600","journal-title":"Cell"},{"key":"5_CR46","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/jnci\/95.3.214","volume":"95","author":"S Hahn","year":"2003","unstructured":"Hahn S, Greenhalf B, Ellis I et al (2003) BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 95:214\u2013221","journal-title":"J Natl Cancer Inst"},{"key":"5_CR47","doi-asserted-by":"crossref","unstructured":"Hampel H, Bennett RL, Buchanan A et al (2014) A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Genet Med","DOI":"10.1038\/gim.2014.147"},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1158\/1078-0432.CCR-06-0083","volume":"12","author":"N Hearle","year":"2006","unstructured":"Hearle N, Schumacher V, Menko FH et al (2006) Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12:3209\u20133215","journal-title":"Clin Cancer Res"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ijc.10863","volume":"103","author":"K Hemminki","year":"2003","unstructured":"Hemminki K, Li X (2003) Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer 103:525\u2013530","journal-title":"Int J Cancer"},{"key":"5_CR50","doi-asserted-by":"crossref","unstructured":"Holter S, Borgida A, Dodd A et al (2015) Germline BRCA mutations in a large clinic-based cohort of patients with pancreatic adenocarcinoma. J Clin Oncol","DOI":"10.1158\/1538-7445.CANSUSC14-12"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S1542-3565(04)00013-8","volume":"2","author":"N Howes","year":"2004","unstructured":"Howes N, Lerch MM, Greenhalf W et al (2004) Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2:252\u2013261","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5_CR52","first-page":"2969","volume":"6","author":"RH Hruban","year":"2000","unstructured":"Hruban RH, Goggins M, Parsons J, Kern SE (2000) Progression model for pancreatic cancer. Clin Cancer Res 6:2969\u20132972","journal-title":"Clin Cancer Res"},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/01.pas.0000126675.59108.80","volume":"28","author":"RH Hruban","year":"2004","unstructured":"Hruban RH, Takaori K, Klimstra DS et al (2004) An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 28:977\u2013987","journal-title":"Am J Surg Pathol"},{"key":"5_CR54","first-page":"306","volume":"1","author":"RH Hruban","year":"2008","unstructured":"Hruban RH, Maitra A, Goggins M (2008) Update on pancreatic intraepithelial neoplasia. Int J Clin Experimen Pathol 1:306","journal-title":"Int J Clin Experimen Pathol"},{"key":"5_CR55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.yasu.2010.05.011","volume":"44","author":"R Hruban","year":"2010","unstructured":"Hruban R, Canto M, Goggins M, Schulick R, Klein A (2010) Update on familial pancreatic cancer. Adv Surg 44:293\u2013311","journal-title":"Adv Surg"},{"key":"5_CR56","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nature08987","volume":"464","author":"TJ Hudson","year":"2010","unstructured":"Hudson TJ, Anderson W, Artez A et al (2010) International network of cancer genome projects. Nature 464:993\u2013998","journal-title":"Nature"},{"key":"5_CR57","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1038\/bjc.2012.483","volume":"107","author":"J Iqbal","year":"2012","unstructured":"Iqbal J, Ragone A, Lubinski J et al (2012) The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer 107:2005\u20132009","journal-title":"Br J Cancer"},{"key":"5_CR58","doi-asserted-by":"crossref","unstructured":"Jabbar KS, Verbeke C, Hyltander AG et al (2014) Proteomic mucin profiling for the identification of cystic precursors of pancreatic cancer J National Cancer Institute 106","DOI":"10.1093\/jnci\/djt439"},{"key":"5_CR59","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1126\/science.1171202","volume":"324","author":"S Jones","year":"2009","unstructured":"Jones S, Hruban RH, Kamiyama M et al (2009) Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 324:217","journal-title":"Science"},{"key":"5_CR60","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1001\/jama.2009.1529","volume":"302","author":"F Kastrinos","year":"2009","unstructured":"Kastrinos F, Mukherjee B, Tayob N et al (2009) Risk of pancreatic cancer in families with Lynch syndrome. JAMA 302:1790\u20131795","journal-title":"JAMA"},{"key":"5_CR61","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1200\/JCO.2014.56.2728","volume":"33","author":"B Kaufman","year":"2015","unstructured":"Kaufman B, Shapira-Frommer R, Schmutzler RK et al (2015) Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1\/2 Mutation. J Clin Oncol 33:244\u2013250","journal-title":"J Clin Oncol"},{"issue":"4","key":"5_CR504","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/S0016-5107(02)70092-8","volume":"56","author":"Michael B. Kimmey","year":"2002","unstructured":"Kimmey M, Bronner M, Byrd D, Brentnall T (2002). Screening and surveillance for hereditary pancreatic cancer. Gastrointest Endosc 56(4 Suppl):S82\u20136","journal-title":"Gastrointestinal Endoscopy"},{"key":"5_CR62","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/nrc3420","volume":"13","author":"A Klein","year":"2013","unstructured":"Klein A (2013a) Identifying people at a high risk of developing pancreatic cancer. Nat Rev Cancer 13:66\u201374. doi: 10.1038\/nrc3420 Epub 2012 Dec 6","journal-title":"Nat Rev Cancer"},{"key":"5_CR63","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/nrc3420","volume":"13","author":"AP Klein","year":"2013","unstructured":"Klein AP (2013b) Identifying people at a high risk of developing pancreatic cancer. Nat Rev Cancer 13:66\u201374","journal-title":"Nat Rev Cancer"},{"key":"5_CR64","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/gepi.1102","volume":"23","author":"AP Klein","year":"2002","unstructured":"Klein AP, Beaty TH, Bailey-Wilson JE et al (2002) Evidence for a major gene influencing risk of pancreatic cancer. Genet Epidemiol 23:133\u2013149","journal-title":"Genet Epidemiol"},{"key":"5_CR65","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1158\/0008-5472.CAN-03-3823","volume":"64","author":"AP Klein","year":"2004","unstructured":"Klein AP, Brune KA, Petersen GM et al (2004) Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 64:2634\u20132638","journal-title":"Cancer Res"},{"key":"5_CR66","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1158\/1078-0432.CCR-05-0564","volume":"12","author":"J Koopmann","year":"2006","unstructured":"Koopmann J, Rosenzweig CNW, Zhang Z et al (2006) Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9. Clin Cancer Res 12:442\u2013446","journal-title":"Clin Cancer Res"},{"key":"5_CR67","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/jmedgenet-2012-101277","volume":"50","author":"SE Korsse","year":"2013","unstructured":"Korsse SE, Harinck F, van Lier MGF et al (2013) Pancreatic cancer risk in Peutz-Jeghers syndrome patients: a large cohort study and implications for surveillance. J Med Genet 50:59\u201364","journal-title":"J Med Genet"},{"key":"5_CR68","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/humu.21446","volume":"32","author":"RP Kuiper","year":"2011","unstructured":"Kuiper RP, Vissers LE, Venkatachalam R et al (2011) Recurrence and variability of germline EPCAM deletions in Lynch syndrome. Hum Mutat 32:407\u2013414","journal-title":"Hum Mutat"},{"key":"5_CR69","first-page":"409","volume":"60","author":"G Lal","year":"2000","unstructured":"Lal G, Liu G, Schmocker B et al (2000) Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res 60:409\u2013416","journal-title":"Cancer Res"},{"issue":"10","key":"5_CR508","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1136\/gut.2008.171611","volume":"58","author":"P Langer","year":"2009","unstructured":"Langer P, Kann PH, Fendrich V, Habbe N, Schneider M, Sina M et al (2009). Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer. Gut 58(10):1410\u20131418","journal-title":"Gut"},{"key":"5_CR70","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1158\/0008-5472.CAN-14-0734","volume":"74","author":"AM Lennon","year":"2014","unstructured":"Lennon AM, Wolfgang CL, Canto MI et al (2014) The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia? Cancer Res 74:3381\u20133389","journal-title":"Cancer Res"},{"key":"5_CR71","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.dld.2011.12.019","volume":"44","author":"G Leonardi","year":"2012","unstructured":"Leonardi G, Marchi S, Falconi M et al (2012) \u201cPancPro\u201d as a tool for selecting families eligible for pancreatic cancer screening: an Italian study of incident cases. Dig Liver Dis 44:585\u2013588","journal-title":"Dig Liver Dis"},{"key":"5_CR72","doi-asserted-by":"publisher","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","volume":"71","author":"FP Li","year":"1969","unstructured":"Li FP, Fraumeni JJF (1969) Soft-tissue sarcomas, breast cancer, and other neoplasmsa familial syndrome? Ann Intern Med 71:747\u2013752","journal-title":"Ann Intern Med"},{"key":"5_CR73","unstructured":"Li FP, Fraumeni JF Jr., Mulvihill JJ et al (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358\u20135362"},{"key":"5_CR74","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10552-010-9686-3","volume":"22","author":"D Li","year":"2011","unstructured":"Li D, Tang H, Hassan MM et al (2011) Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control 22:189\u2013197","journal-title":"Cancer Causes Control"},{"key":"5_CR75","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/ng.283","volume":"41","author":"MJ Ligtenberg","year":"2009","unstructured":"Ligtenberg MJ, Kuiper RP, Chan TL et al (2009) Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3\u2019 exons of TACSTD1. Nat Genet 41:112\u2013117","journal-title":"Nat Genet"},{"key":"5_CR76","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1373\/clinchem.2011.172767","volume":"58","author":"R Liu","year":"2012","unstructured":"Liu R, Chen X, Du Y et al (2012) Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 58:610\u2013618","journal-title":"Clin Chem"},{"key":"5_CR77","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/jnci\/89.6.442","volume":"89","author":"AB Lowenfels","year":"1997","unstructured":"Lowenfels AB, Maisonneuve P, Dimagno EP et al (1997) Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 89:442\u2013446","journal-title":"J Natl Cancer Inst"},{"key":"5_CR78","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1001\/jama.286.2.169","volume":"286","author":"AB Lowenfels","year":"2001","unstructured":"Lowenfels AB, Maisonneuve P, Whitcomb DC et al (2001) Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 286:169\u2013170","journal-title":"JAMA"},{"key":"5_CR79","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1200\/JCO.2013.50.9257","volume":"32","author":"KH Lu","year":"2014","unstructured":"Lu KH, Wood ME, Daniels M et al (2014) American society of clinical oncology expert statement: collection and use of a cancer family history for oncology providers. J Clin Oncol 32:833\u2013840","journal-title":"J Clin Oncol"},{"key":"5_CR80","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1158\/1078-0432.CCR-12-3020","volume":"19","author":"AL Lucas","year":"2013","unstructured":"Lucas AL, Shakya R, Lipsyc MD et al (2013) High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions. Clin Cancer Res 19:3396\u20133403","journal-title":"Clin Cancer Res"},{"issue":"5","key":"5_CR511","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/ajg.2011.65","volume":"106","author":"Emmy Ludwig","year":"2011","unstructured":"Ludwig E, Olson SH, Bayuga S, Simon J, Schattner MA, Gerdes H et al (2011). Feasibility and yield of screening in relatives from familial pancreatic cancer families. Am J Gastroenterol 106(5):946\u2013954","journal-title":"American Journal of Gastroenterology"},{"key":"5_CR81","first-page":"54","volume":"85","author":"H Lynch","year":"1990","unstructured":"Lynch H, Fitzsimmons M, Smyrk T et al (1990) Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. Am J Gastroenterol 85:54\u201360","journal-title":"Am J Gastroenterol"},{"key":"5_CR82","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature13127","volume":"508","author":"DG Macarthur","year":"2014","unstructured":"Macarthur DG, Manolio TA, Dimmock DP et al (2014) Guidelines for investigating causality of sequence variants in human disease. Nature 508:469\u2013476","journal-title":"Nature"},{"key":"5_CR83","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nature08494","volume":"461","author":"TA Manolio","year":"2009","unstructured":"Manolio TA, Collins FS, Cox NJ et al (2009) Finding the missing heritability of complex diseases. Nature 461:747\u2013753","journal-title":"Nature"},{"key":"5_CR84","first-page":"252","volume":"55","author":"C McFaul","year":"2006","unstructured":"McFaul C, Greenhalf W, Earl J et al (2006) Anticipation in familial pancreatic cancer. Gut. 55:252\u2013258 Epub 2005 Jun 21","journal-title":"Anticipation in familial pancreatic cancer. Gut."},{"key":"5_CR85","unstructured":"McGarrity TJ, Amos C, Frazier ML et al (2013) Peutz-Jeghers Syndrome. 2001 Feb 23 (Updated 2013 Jul 25). In: Pagon RA, Adam MP, Ardinger HH et al (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle (WA), 1993\u20132014. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1266\/"},{"key":"5_CR86","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10689-011-9506-2","volume":"11","author":"A Moran","year":"2012","unstructured":"Moran A, O\u2019Hara C, Khan S et al (2012) Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations. Fam Cancer 11:235\u2013242. doi: 10.1007\/s10689-011-9506-2","journal-title":"Fam Cancer"},{"key":"5_CR87","first-page":"271","volume":"4","author":"HE Mulcahy","year":"1998","unstructured":"Mulcahy HE, Lyautey J, Lederrey C et al (1998) A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res 4:271\u2013275","journal-title":"Clin Cancer Res"},{"key":"5_CR88","first-page":"3789","volume":"62","author":"KM Murphy","year":"2002","unstructured":"Murphy KM, Brune KA, Griffin C et al (2002) Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17\u00a0%. Cancer Res 62:3789\u20133793","journal-title":"Cancer Res"},{"key":"5_CR89","unstructured":"National Comprehensive Cancer Network guidelines for prevention, detection and risk reduction. Genetic\/familial high-risk assessment: Breast and ovarian version 2.2015. www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp . Accessed 15th December 2015"},{"key":"5_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jso.23149","volume":"107","author":"S Olson","year":"2013","unstructured":"Olson S, Kurtz R (2013) Epidemiology of pancreatic cancer and the role of family history. J Surg Oncol 107:1\u20137. doi: 10.1002\/jso.23149 Epub 2012 May 15","journal-title":"J Surg Oncol"},{"key":"5_CR91","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng0597-17","volume":"16","author":"H Ozcelik","year":"1997","unstructured":"Ozcelik H, Schmocker B, di Nicola N et al (1997) Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet 16:17\u201318","journal-title":"Nat Genet"},{"key":"5_CR92","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/1055-9965.EPI-05-0734","volume":"15","author":"GM Petersen","year":"2006","unstructured":"Petersen GM, de Andrade M, Goggins M et al (2006) Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev 15:704\u2013710","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5_CR93","doi-asserted-by":"publisher","first-page":"e516","DOI":"10.1371\/journal.pmed.0030516","volume":"3","author":"KL Pogue-Geile","year":"2006","unstructured":"Pogue-Geile KL, Chen R, Bronner MP et al (2006) Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med 3:e516","journal-title":"PLoS Med"},{"issue":"9","key":"5_CR507","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/ajg.2009.276","volume":"104","author":"J W Poley","year":"2009","unstructured":"Poley JW, Kluijt I, Gouma DJ, Harinck F, Wagner A, Aalfs C et al (2009). The Yield of First-Time Endoscopic Ultrasonography in Screening Individuals at a High Risk of Developing Pancreatic Cancer. Am J Gastroenterol 104(9):2175\u20132181","journal-title":"The American Journal of Gastroenterology"},{"key":"5_CR94","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrgastro.2009.177","volume":"6","author":"S Raimondi","year":"2009","unstructured":"Raimondi S, Maisonneuve P, Lowenfels A (2009) Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol. 6:699\u2013708. doi: 10.1038\/nrgastro.2009.177 Epub 2009 Oct 6","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"5_CR95","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/gut.2008.149179","volume":"58","author":"V Rebours","year":"2009","unstructured":"Rebours V, Boutron-Ruault MC, Schnee M et al (2009) The natural history of hereditary pancreatitis: a national series. Gut 58:97\u2013103","journal-title":"Gut"},{"key":"5_CR96","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/jnci\/djj465","volume":"98","author":"HA Risch","year":"2006","unstructured":"Risch HA, McLaughlin JR, Cole DE et al (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98:1694\u20131706","journal-title":"J Natl Cancer Inst"},{"key":"5_CR97","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1158\/2159-8290.CD-11-0194","volume":"2","author":"N Roberts","year":"2012","unstructured":"Roberts N, Jiao Y, Yu J et al (2012a) ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov 2:41\u201346. doi: 10.1158\/2159-8290.CD-11-0194 Epub 2011 Dec 29","journal-title":"Cancer Discov"},{"key":"5_CR98","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1158\/2159-8290.CD-11-0194","volume":"2","author":"NJ Roberts","year":"2012","unstructured":"Roberts NJ, Jiao Y, Yu J et al (2012b) ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov 2:41\u201346","journal-title":"Cancer Discov"},{"key":"5_CR99","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/jmg.2009.073429","volume":"47","author":"MW Ruijs","year":"2010","unstructured":"Ruijs MW, Verhoef S, Rookus MA et al (2010) TP53 germline mutation testing in 180 families suspected of Li\u2013Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. J Med Genet 47:421\u2013428","journal-title":"J Med Genet"},{"key":"5_CR100","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/cncr.20669","volume":"101","author":"JL Rutter","year":"2004","unstructured":"Rutter JL, Bromley CM, Goldstein AM et al (2004) Heterogeneity of risk for melanoma and pancreatic and digestive malignancies. Cancer 101:2809\u20132816","journal-title":"Cancer"},{"key":"5_CR101","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1056\/NEJMra1404198","volume":"371","author":"DP Ryan","year":"2014","unstructured":"Ryan DP, Hong TS, Bardeesy N (2014) Pancreatic adenocarcinoma. N Engl J Med 371:1039\u20131049","journal-title":"N Engl J Med"},{"key":"5_CR102","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10689-010-9414-x","volume":"10","author":"R Schneider","year":"2011","unstructured":"Schneider R, Slater E, Sina M et al (2011a) German national case collection for familial pancreatic cancer (FaPaCa): ten years experience. Fam Cancer 10:323\u2013330. doi: 10.1007\/s10689-010-9414-x","journal-title":"Fam Cancer"},{"key":"5_CR103","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10689-010-9414-x","volume":"10","author":"R Schneider","year":"2011","unstructured":"Schneider R, Slater EP, Sina M et al (2011b) German national case collection for familial pancreatic cancer (FaPaCa): ten years experience. Fam Cancer 10:323\u2013330","journal-title":"Fam Cancer"},{"key":"5_CR104","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5858\/133.3.365","volume":"133","author":"C Shi","year":"2009","unstructured":"Shi C, Hruban RH, Klein AP (2009) Familial pancreatic cancer. Arch Pathol Lab Med 133:365\u2013374","journal-title":"Arch Pathol Lab Med"},{"key":"5_CR105","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cancergencyto.2007.08.002","volume":"179","author":"S Skudra","year":"2007","unstructured":"Skudra S, Staka A, Pukitis A et al (2007) Association of genetic variants with pancreatic cancer. Cancer Genet Cytogenet 179:76\u201378","journal-title":"Cancer Genet Cytogenet"},{"key":"5_CR106","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1200\/JCO.2013.49.7271","volume":"32","author":"ZK Stadler","year":"2014","unstructured":"Stadler ZK, Schrader KA, Vijai J, Robson ME, Offit K (2014) Cancer genomics and inherited risk. J Clin Oncol 32:687\u2013698","journal-title":"J Clin Oncol"},{"key":"5_CR107","first-page":"350","volume":"85","author":"W Steinberg","year":"1990","unstructured":"Steinberg W (1990) The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol 85:350\u2013355","journal-title":"Am J Gastroenterol"},{"key":"5_CR108","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ajg.2014.435","volume":"110","author":"S Syngal","year":"2015","unstructured":"Syngal S, Brand RE, Church JM et al (2015) ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110:223\u2013262","journal-title":"Am J Gastroenterol"},{"key":"5_CR109","first-page":"738","volume":"7","author":"A Tersmette","year":"2001","unstructured":"Tersmette A, Petersen G, Offerhaus G et al (2001) Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 7:738\u2013744","journal-title":"Clin Cancer Res"},{"key":"5_CR501","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Network (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407):330\u2013337","DOI":"10.1038\/nature11252"},{"key":"5_CR110","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1086\/318181","volume":"68","author":"D Thompson","year":"2001","unstructured":"Thompson D, Easton D (2001) Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 68:410\u2013419","journal-title":"Am J Hum Genet"},{"key":"5_CR111","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1053\/j.gastro.2009.06.055","volume":"137","author":"MD Tischkowitz","year":"2009","unstructured":"Tischkowitz MD, Sabbaghian N, Hamel N et al (2009) Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer. Gastroenterology 137:1183\u20131186","journal-title":"Gastroenterology"},{"key":"5_CR112","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/1097-0215(20000915)87:6<809::AID-IJC8>3.0.CO;2-U","volume":"87","author":"HFA Vasen","year":"2000","unstructured":"Vasen HFA, Gruis NA, Frants RR et al (2000) Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 87:809\u2013811","journal-title":"Int J Cancer"},{"issue":"Supplement 4","key":"5_CR113","doi-asserted-by":"crossref","first-page":"iv51","DOI":"10.1093\/annonc\/mdp127","volume":"20","author":"H. F. A. Vasen","year":"2009","unstructured":"Vasen HFA, van der Meulen\u2013de Jong AE, de vos tot Nederveen Cappel WH, Oliveira J (2009) GROUP, O. B. O. T. E. G. W. 2009 Familial colorectal cancer risk: ESMO Clinical Recommendations. Annals of Oncology 20:iv51\u2013iv53","journal-title":"Annals of Oncology"},{"issue":"20","key":"5_CR509","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1158\/1078-0432.CCR-09-3209","volume":"16","author":"E. C. Verna","year":"2010","unstructured":"Verna EC, Hwang C, Stevens PD, Rotterdam H, Stavropoulos SN, Sy CD et al (2010). Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics. Clinical cancer research 16(20):5028\u20135037","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"5_CR510","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.gastro.2010.11.048","volume":"140","author":"Hans F.A. Vasen","year":"2011","unstructured":"Vasen HF, Wasser M, van Mil A, Tollenaar RA, Konstantinovski M, Gruis NA et al (2011). Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. Gastroenterology 140(3):850\u2013856","journal-title":"Gastroenterology"},{"key":"5_CR114","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell N, Pajic M, Patch A-M et al (2015) Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518:495\u2013501","journal-title":"Nature"},{"key":"5_CR115","doi-asserted-by":"publisher","first-page":"18032","DOI":"10.1073\/pnas.1115052108","volume":"108","author":"T Walsh","year":"2011","unstructured":"Walsh T, Casadei S, Lee MK et al (2011) Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci 108:18032\u201318037","journal-title":"Proc Natl Acad Sci"},{"key":"5_CR116","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1200\/JCO.2006.09.2452","volume":"25","author":"W Wang","year":"2007","unstructured":"Wang W, Chen S, Brune KA et al (2007) PancPRO: risk assessment for individuals with a family history of pancreatic cancer. J Clin Oncol 25:1417\u20131422","journal-title":"J Clin Oncol"},{"key":"5_CR117","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1158\/1055-9965.EPI-09-0557","volume":"18","author":"L Wang","year":"2009","unstructured":"Wang L, Brune K, Visvanathan K et al (2009a) Elevated cancer mortality in the relatives of patients with pancreatic cancer. Cancer Epidemiol Biomarkers Prev 18:2829\u20132834. doi: 10.1158\/1055-9965.EPI-09-0557 Epub 2009 Oct 20","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5_CR118","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1158\/1055-9965.EPI-09-0557","volume":"18","author":"L Wang","year":"2009","unstructured":"Wang L, Brune KA, Visvanathan K et al (2009b) Elevated cancer mortality in the relatives of patients with pancreatic cancer. Cancer Epidemiol Biomark Prev 18:2829\u20132834","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"5_CR119","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/ng1096-141","volume":"14","author":"DC Whitcomb","year":"1996","unstructured":"Whitcomb DC, Gorry MC, Preston RA et al (1996) Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 14:141\u2013145","journal-title":"Nat Genet"},{"key":"5_CR120","doi-asserted-by":"crossref","unstructured":"Whitcomb DC, Shelton C, Brand RE (2015) Genetics and genetic testing in pancreatic cancer. Gastroenterology","DOI":"10.1053\/j.gastro.2015.07.057"},{"key":"5_CR121","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nature09515","volume":"467","author":"S Yachida","year":"2010","unstructured":"Yachida S, Jones S, Bozic I et al (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467:1114\u20131117","journal-title":"Nature"},{"key":"5_CR122","doi-asserted-by":"crossref","unstructured":"Zhen DB, Rabe KG, Gallinger S et al (2014) BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med","DOI":"10.1038\/gim.2014.153"},{"key":"5_CR123","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00439-007-0361-z","volume":"121","author":"G Zogopoulos","year":"2007","unstructured":"Zogopoulos G, Rothenmund H, Eppel A et al (2007) The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer. Hum Genet 121:635\u2013637","journal-title":"Hum Genet"}],"container-title":["Recent Results in Cancer Research","Rare Hereditary Cancers"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-29998-3_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T20:17:18Z","timestamp":1655497038000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-29998-3_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319299969","9783319299983"],"references-count":135,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-29998-3_5","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"type":"print","value":"0080-0015"},{"type":"electronic","value":"2197-6767"}],"subject":[],"published":{"date-parts":[[2016]]}}}